[HTML][HTML] Structural biology of SARS-CoV-2: open the door for novel therapies
W Yan, Y Zheng, X Zeng, B He, W Cheng - Signal Transduction and …, 2022 - nature.com
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
[PDF][PDF] Structural biology of SARS-CoV-2: open the door for novel therapies
2022 - scienceopen.com
SARS-CoV-2, a novel human coronavirus, broke out in December 2019 and has infected
more than 230 million people and caused 4.87 million deaths, according to the latest data …
more than 230 million people and caused 4.87 million deaths, according to the latest data …
Structural biology of SARS-CoV-2: open the door for novel therapies
W Yan, Y Zheng, X Zeng, B He, W Cheng - 2022 - agris.fao.org
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
Structural biology of SARS-CoV-2: open the door for novel therapies
Y Weizhu, Z Yanhui, Z Xiaotao, B He… - … and Targeted Therapy, 2022 - search.proquest.com
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
Structural biology of SARS-CoV-2: open the door for novel therapies
W Yan, Y Zheng, X Zeng, B He, W Cheng - Signal Transduction and …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2) is the causative agent of the pandemic disease COVID-19 …
Coronavirus-2 (SARS-CoV-2) is the causative agent of the pandemic disease COVID-19 …
[HTML][HTML] Structural biology of SARS-CoV-2: open the door for novel therapies
W Yan, Y Zheng, X Zeng, B He… - Signal Transduction and …, 2022 - ncbi.nlm.nih.gov
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
Structural biology of SARS-CoV-2: open the door for novel therapies
W Yan, Y Zheng, X Zeng, B He… - … and targeted therapy, 2022 - pubmed.ncbi.nlm.nih.gov
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative agent of
the pandemic disease COVID-19, which is so far without efficacious treatment. The …
the pandemic disease COVID-19, which is so far without efficacious treatment. The …
Structural biology of SARS-CoV-2: open the door for novel therapies.
W Yan, Y Zheng, X Zeng, B He… - Signal Transduction and …, 2022 - europepmc.org
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
Structural biology of SARS-CoV-2: open the door for novel therapies.
W Yan, Y Zheng, X Zeng, B He… - Signal Transduction & …, 2022 - search.ebscohost.com
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …